Among 1,363 women treated for cervical cancer at SOLCA Quito, those first seen in the public system and then referred waited a mean of 162 days to start treatment, against 62 days for those cared for at SOLCA throughout, and the delay was linked to shorter survival in advanced stages.
Published as "Impact of treatment delay on survival in women diagnosed with cervical cancer in Quito, Ecuador: a retrospective cohort study". A retrospective cohort of patients diagnosed between 2012 and 2015 and treated at SOLCA Quito, grouped by whether their care began in the public health system with later referral to SOLCA or was given entirely at SOLCA, and by FIGO 2009 stage.
Shows the cost of the referral path between Ecuador's public network and SOLCA: women who entered through the public system started treatment about three months later, and in advanced stages this was linked to shorter survival.
Shares SOLCA Núcleo de Quito, Hospital Oncológico Solón Espinosa Ayala, Ministerio de Salud Pública del Ecuador.
Shares SOLCA Núcleo de Quito, Hospital Oncológico Solón Espinosa Ayala, Ministerio de Salud Pública del Ecuador, Cervical cancer.
Shares SOLCA Núcleo de Quito, Hospital Oncológico Solón Espinosa Ayala, Ministerio de Salud Pública del Ecuador, Cervical cancer.
Shares SOLCA Núcleo de Quito, Hospital Oncológico Solón Espinosa Ayala, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/